Mercury Laboratories appoints Binaya Kumar Panigrahi as Plant Head

1 min read     Updated on 11 Jun 2026, 05:15 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Mercury Laboratories Limited has appointed Mr. Binaya Kumar Panigrahi as the Plant Head for its Jarod Unit effective June 11, 2026. Panigrahi, a B.Pharm graduate with over 24 years of experience in tablet manufacturing, previously worked with Coral Laboratories Limited and Biocon Biological India Limited. The appointment was disclosed to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
42723908

*this image is generated using AI for illustrative purposes only.

Mercury Laboratories Limited has appointed Mr. Binaya Kumar Panigrahi as the Plant Head for its Jarod Unit, effective June 11, 2026. The appointment aims to strengthen the company's manufacturing operations with the addition of a senior management professional possessing extensive industry experience.

The appointment was made pursuant to Regulation 30 read with Para A(7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was submitted to the stock exchanges to comply with the regulatory framework governing senior management personnel changes.

Profile of the Appointee

Mr. Binaya Kumar Panigrahi, aged about 52 years, holds a Bachelor degree in Pharmacy (B.Pharm). He possesses a rich experience of more than 24 years specifically in the domain of Tablet Manufacturing. Prior to this role, he was associated with Coral Laboratories Limited and Biocon Biological India Limited, Bangalore.

Appointment Details

The following table outlines the key details regarding the new appointment:

Sr. No Detail Information
1. Reason for change Mr. Binaya Kumar Panigrahi appointed as Plant Head (Jarod Unit)
2. Date of appointment June 11, 2026
3. Term of appointment Full time employment
4. Disclosure of relationships Not applicable

The company has informed the BSE Limited regarding this change in its senior management personnel. The intimation was signed by Rajendra Shah, Managing Director of Mercury Laboratories Limited.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.13%+1.04%-1.77%-6.88%-6.53%+5.74%

How will Mr. Panigrahi's expertise in tablet manufacturing influence Mercury Laboratories' production capacity and operational efficiency?

What strategic initiatives does the company plan to implement under the new Plant Head to expand the Jarod Unit's capabilities?

Could this appointment signal a shift in Mercury Laboratories' product portfolio or a focus on specific therapeutic areas?

Mercury Laboratories fixes book closure for ₹3.50 dividend

1 min read     Updated on 29 May 2026, 04:15 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Mercury Laboratories Limited announced a book closure from September 22, 2026, to September 28, 2026, for its 45th Annual General Meeting and the payment of a final dividend of ₹3.50 per share. The record date for dividend eligibility is September 21, 2026. The company previously reported a 53.7% rise in FY26 net profit to ₹483.40 crore.

powered bylight_fuzz_icon
41087858

*this image is generated using AI for illustrative purposes only.

Mercury Laboratories Limited announced that its Register of Members and Share Transfer books will remain closed from September 22, 2026, to September 28, 2026, for the 45th Annual General Meeting and the payment of the final dividend. The company has fixed September 21, 2026, as the record date to determine shareholder eligibility for the dividend payout of ₹3.50 per share, subject to approval at the AGM scheduled for September 28, 2026.

The board had previously recommended the final dividend of ₹3.50 per share alongside the financial results for the year ended March 31, 2026. The AGM will be conducted via Video Conferencing. The dividend payment is contingent upon shareholder approval during the meeting.

Book Closure and AGM Details

Particulars Details
Book Closure From September 22, 2026
Book Closure To September 28, 2026
Record Date September 21, 2026
AGM Date September 28, 2026
Dividend ₹3.50 per share

The company reported a 53.7% increase in net profit to ₹483.40 crore for FY26, compared to ₹314.49 crore in the previous year. Revenue from operations rose to ₹7,593.67 crore from ₹7,510.12 crore in FY25.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.13%+1.04%-1.77%-6.88%-6.53%+5.74%

How will the proposed ₹3.50 dividend impact Mercury Laboratories' free cash flow and capital allocation plans for FY27?

Given the 53.7% profit surge, is the company considering increasing its dividend payout ratio in future fiscal years?

What strategic initiatives or market factors drove the significant net profit growth relative to the modest revenue increase?

More News on Mercury Laboratories

1 Year Returns:-6.53%